Skip to content

Mindfulness-based social cognition training (SocialMIND) versus psychoeducational multicomponent intervention for people with a first episode of psychosis: a study protocol for a randomised controlled trial.

Roberto Mediavilla, Ainoa Muñoz-Sanjosé, Beatriz Rodriguez-Vega, Carmen Bayón, Angela Palao, Guillermo Lahera, Pilar Sanchez-Castro, Eva Roman, Susana Cebolla, Alvaro De Diego, Juan Manuel Pastor, Maria-Fe Bravo-Ortiz

BMC Psychiatry July 29, 2019 DOI: 10.1186/s12888-019-2206-4 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial (parallel-group, single-blind evaluator, active-comparator, superiority; protocol) Peer reviewed
Sample size 80
Population People who have recently experienced a first episode of psychosis
Interventions SocialMIND psychoeducational multicomponent intervention (PMI)
Duration Eight weekly sessions, four bi-weekly sessions, and five monthly sessions; assessments at weeks 8, 16, and 56, plus 3 months after completing the intervention (week 68)
Measures Personal and Social Performance (PSP) scale
Topics Meditation
Keywords Humans Treatment outcome Single-blind method Social behavior Psychotic disorders Psychotherapy Adult Female Cognitive behavioral therapy Psychological intervention Psychosis Social cognition Social functioning Schizophrenia spectrum disorders Real-life outcomes
Registration NCT03309475
Key findings The protocol proposes that SocialMIND, a mindfulness-based social cognition training, will produce changes in real-life functioning and be at least as effective as a psychoeducational multicomponent intervention for people with a first episode of psychosis. No outcome data are reported; the trial is designed to detect clinically significant differences in social functioning.

Abstract

Background: People who suffer a first episode of psychosis experience higher levels of distress and suffering. Early intervention programs combine pharmacological and psychosocial strategies that include different components, such as cognitive-behavioural therapy, psychosocial interventions, medication adherence, family psychoeducation, counselling, etc. Among the complementary approaches, mindfulness-based interventions help participants to cultivate a radical acceptance of their psychotic experiences within a person-centered framework. They show promising results for people with longer duration of psychosis, but there is still no evidence for people who have recently experienced their first episode of psychosis.

Methods: The present parallel-group, single-blind (evaluator), randomised (1:1 ratio), controlled (versus active comparator), superiority, clinical trial will compare the effectiveness of SocialMIND on social functioning as measured by the Personal and Social Performance (PSP) scale. The active comparator will be a psychoeducational multicomponent intervention (PMI) that incorporates elements of early intervention programs that are effective for people who have suffered a first episode of psychosis. Both SocialMIND and PMI encompass eight weekly sessions, four bi-weekly sessions, and five monthly sessions. Changes in primary and secondary outcomes will be measured after weekly (8th week), bi-weekly (16th week) and monthly sessions (56th week), and 3 months after completing the intervention (68th week). Secondary outcomes include symptoms of psychosis, anxiety and depression, as well as indicators of general functioning. Tertiary outcomes are measures of social cognition, neurocognition, mindfulness, and indicators of inflammation and oxidative stress. A final sample of 80 participants is proposed to detect clinically significant differences in social functioning.

Discussion: This is the first mindfulness-based social cognition training for people with psychosis. SocialMIND aims to generate changes in the real-life functioning of people who have experienced a first episode of psychosis, and to be at least as effective as a psychoeducational multicomponent program. Adherence to the interventions is a common problem among young people with psychosis, so several difficulties are anticipated, and some methodological issues are discussed.

Trial Registration: The trial was registered in ClinicalTrials.gov in October 2018 (NCT03309475).

Comparable studies

Other randomized controlled trials on meditation, most cited first.

Study Year Design Participants
Alterations in Brain and Immune Function Produced by Mindfulness Meditation Healthy employees in a work environment 2003 Randomized controlled trial n = 41
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Open hearts build lives: Positive emotions, induced through loving-kindness meditation, build consequential personal resources. Working adults 2008 Randomized controlled trial n = 139
Short-term meditation training improves attention and self-regulation Undergraduate Chinese students 2007 Randomized controlled trial n = 40
Mindfulness-Based Cognitive Therapy for Depression: Replication and Exploration of Differential Relapse Prevention Effects. Recovered recurrently depressed patients 2004 Randomized controlled trial n = 73

Citations in the library

Explore topics